Zein-Based Nanomedicines for Synergistic Chemodynamic/Photodynamic Therapy. 2022

Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
College of Food Science and Engineering, National Engineering Laboratory for Wheat and Corn Deep Processing, Jilin Agricultural University, Changchun, Jilin 130118, China.

Current cancer treatment is not only limited to monotherapy but is also influenced by limited drug delivery options. Combined chemokinetic-photokinetic therapy has great promise in enhancing anticancer effects. Meanwhile, zein has superior self-assembly properties and can be loaded with photosensitizers. Herein, the targeted multifunctional nanoparticles based on zein/hyaluronate acid (HA)/tannin (TA)/Cu2+ loaded with IR780 (ZHTC@IR780) are constructed for synergetic cancer therapy by chemo-dynamic therapy (CDT) and photodynamic therapy (PDT). There is experimental proof that ZHTC@IR780 nanoparticles (NPs) can relieve the tumor hypoxic microenvironment by catalytic decomposition of endogenous H2O2 to O2 and further react with O2 to produce toxic 1O2 with 808 nm laser irradiation. The glutathione oxidase-like effects of ZHTC@IR780 NPs can generate Fenton-like Cu+ ions and deplete GSH for efficient hydroxyl radical (•OH) production. In addition, CDT combined with PDT enhances the antitumor effect. Photodynamic therapy can cause immunogenic cell death, increase calreticulin eversion, release histone with high mobility, and promote apoptosis of tumor cells.

UI MeSH Term Description Entries

Related Publications

Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
April 2022, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
July 2020, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology,
Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
December 2023, ACS applied bio materials,
Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
February 2021, Nanoscale,
Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
April 2020, Nature communications,
Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
July 2024, Journal of colloid and interface science,
Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
March 2024, ACS biomaterials science & engineering,
Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
November 2022, ACS applied materials & interfaces,
Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
April 2023, Chemical communications (Cambridge, England),
Xiang Li, and Yupeng Wang, and Qiankun Shi, and Nuo Zhen, and Jin Xue, and Jingsheng Liu, and Dongfang Zhou, and Hao Zhang
December 2020, Nanoscale,
Copied contents to your clipboard!